Literature DB >> 7061450

The formation of lipid-linked oligosaccharides in Madin-Darby canine kidney cells. Changes in oligosaccharide profiles induced by glucosamine.

Y T Pan, A D Elbein.   

Abstract

Glucosamine inhibits the incorporation of [2-3H]mannose into lipid-linked oligosaccharides and into glycoproteins in influenza virus-infected MDCK cells. Fifty per cent inhibition of these components requires about 2 mM glucosamine. The oligosaccharide portions of the lipid-linked oligosaccharides in cells inhibited with glucosamine were compared to that of normal cells by chromatography on Bio-Gel P-4 columns. In uninhibited cells, the major oligosaccharide formed from [2-3H]mannose was the Glc3Man9GlcNAc2 species as demonstrated by the products of endoglucosaminidase H and alpha-mannosidase digestion. At low concentrations of glucosamine (approximately 2 mM) or in short term incubations (1 to 2 h), the large oligosaccharide disappeared and was replaced by a Man7GlcNAc2 species. This was also characterized by various enzymatic treatments as well as its migration rate on Bio-Gel P-4 as compared to known oligosaccharides. At still higher glucosamine concentrations or longer incubation times, the Man7GlcNAc2 species also disappeared and was replaced by a Man3GlcNAc2 species. The effect of glucosamine was reversible such that when the cells were washed free of this inhibitor, they resumed the synthesis of the Glc3Man9GlcNAc2 species and the other two oligosaccharides disappeared. These smaller oligosaccharides were not observed when glucosamine was replaced by either 5 mM galactosamine or 5 mM N-acetylglucosamine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7061450

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Effects of bleomycin and methylprednisolone on the biosynthesis of oligosaccharide-lipids and glycoproteins in lung.

Authors:  N Mohapatra; W S Lynn; S N Bhattacharyya
Journal:  Biochem J       Date:  1983-09-01       Impact factor: 3.857

Review 2.  Viral glycoprotein metabolism as a target for antiviral substances.

Authors:  H D Klenk; R T Schwarz
Journal:  Antiviral Res       Date:  1982-09       Impact factor: 5.970

3.  Comprehensive manipulation of glycosylation profiles across development scales.

Authors:  Sven Loebrich; Elisa Clark; Kristina Ladd; Stefani Takahashi; Anna Brousseau; Seth Kitchener; Robert Herbst; Thomas Ryll
Journal:  MAbs       Date:  2018-10-22       Impact factor: 5.857

4.  Glucosamine inhibits epidermal growth factor-induced proliferation and cell-cycle progression in retinal pigment epithelial cells.

Authors:  Chang-Min Liang; Ming-Cheng Tai; Yun-Hsiang Chang; Yi-Hao Chen; Ching-Long Chen; Ming-Wei Chien; Jiann-Torng Chen
Journal:  Mol Vis       Date:  2010-12-03       Impact factor: 2.367

Review 5.  Inhibitors of protein glycosylation and glycoprotein processing in viral systems.

Authors:  R Datema; S Olofsson; P A Romero
Journal:  Pharmacol Ther       Date:  1987       Impact factor: 12.310

6.  Mannosamine, a novel inhibitor of glycosylphosphatidylinositol incorporation into proteins.

Authors:  M P Lisanti; M C Field; I W Caras; A K Menon; E Rodriguez-Boulan
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

7.  Proliferative vitreoretinopathy: current and emerging treatments.

Authors:  Ama Sadaka; Gian Paolo Giuliari
Journal:  Clin Ophthalmol       Date:  2012-08-14

Review 8.  Multi-Omics Studies towards Novel Modulators of Influenza A Virus-Host Interaction.

Authors:  Sandra Söderholm; Yu Fu; Lana Gaelings; Sergey Belanov; Laxman Yetukuri; Mikhail Berlinkov; Anton V Cheltsov; Simon Anders; Tero Aittokallio; Tuula A Nyman; Sampsa Matikainen; Denis E Kainov
Journal:  Viruses       Date:  2016-09-29       Impact factor: 5.048

Review 9.  Dissecting glycoprotein biosynthesis by the use of specific inhibitors.

Authors:  W McDowell; R T Schwarz
Journal:  Biochimie       Date:  1988-11       Impact factor: 4.079

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.